Sichuan Hebang Biotechnology Co (SHSE:603077) Accounts Payable & Accrued Expense : ¥2,520 Mil (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Sichuan Hebang Biotechnology Co Accounts Payable & Accrued Expense?

Sichuan Hebang Biotechnology Co's quarterly accounts payable & accrued expense declined from Sep. 2023 (¥2,127 Mil) to Dec. 2023 (¥2,051 Mil) but then increased from Dec. 2023 (¥2,051 Mil) to Mar. 2024 (¥2,520 Mil).

Sichuan Hebang Biotechnology Co's annual accounts payable & accrued expense increased from Dec. 2021 (¥1,447 Mil) to Dec. 2022 (¥2,087 Mil) but then declined from Dec. 2022 (¥2,087 Mil) to Dec. 2023 (¥2,051 Mil).

Sichuan Hebang Biotechnology Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Sichuan Hebang Biotechnology Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sichuan Hebang Biotechnology Co Accounts Payable & Accrued Expense Chart

Sichuan Hebang Biotechnology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1,080.15

1,145.36

1,446.67

2,086.78

2,050.85

Sichuan Hebang Biotechnology Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															1,932.13	2,003.48	2,127.13	2,050.85	2,519.57

Sichuan Hebang Biotechnology Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Sichuan Hebang Biotechnology Co (SHSE:603077) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Sichuan Hebang Biotechnology Co Ltd (SHSE:603077) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

Number 8, Guangfu Road, Building C6, Qingyang District, Sichuan province, Chengdu, CHN, 610073

Website

http://www.hebang.cn

Sichuan Hebang Biotechnology Co Ltd is engaged in manufacturing chemicals. It provides ammonium chloride which is used as raw material for fertilizers. The other chemical products offered by the company are used in various areas.

Executives

Qin Xue Ling	Director
Wang Jun	Director
Mo Rong	Director
He Zheng Gang	Director
Yang Hong Wu	Director
Li Jing Lin	Director
Yang Hui Rong	Director

Sichuan Hebang Biotechnology Co (SHSE:603077) Headlines

No Headlines